Insulet Corporation (PODD) Posts Q2 EPS Loss of $0.42, Tweaks FY11 Sales Guidance
Tweet
Share
E-mailGet Alerts PODD Hot Sheet
Price: $147.48 -2.06%
EPS Growth %: +28.2%
Financial Fact:
Operating loss: 2.42M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +28.2%
Financial Fact:
Operating loss: 2.42M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Insulet Corporation (NASDAQ: PODD) reported Q2 EPS of ($0.42), $0.19 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $32.2 million versus the consensus estimate of $33.05 million.
Insulet Corporation sees FY2011 revenue of $152-$158 million, versus the consensus of $156.37 million.
Insulet Corporation sees FY2011 revenue of $152-$158 million, versus the consensus of $156.37 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ambarella (AMBA) Tops Q2 EPS by 1c; offers guidance
- Samsara Inc (IOT) Tops Q2 EPS by 4c, Beats on Revenue; Offers Q3 Guidance
- John Wiley & Sons, Inc. (WLY) Tops Q1 EPS by 4c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
